Last reviewed · How we verify

NCT04506684

Reveal LINQ Respiration Clinical Study

Completed Last updated 18 December 2023
What this trial tests

trial testing Investigational RAMware downloaded onto Reveal LINQ device in Respiratory Rate in 79 participants. Completed in 31 July 2021.

Timeline
25 September 2020
Primary endpoint
31 July 2021
31 July 2021

Quick facts

Lead sponsorMedtronic Cardiac Rhythm and Heart Failure
StatusCompleted
Study typeOBSERVATIONAL
Enrollment79
Start date25 September 2020
Primary completion31 July 2021
Estimated completion31 July 2021
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Medtronic Cardiac Rhythm and Heart Failure — full company profile →

Who can join

55 and older, any sex, with Respiratory Rate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The LINQ™ Respiration study will collect and characterize Reveal LINQ™ derived respiration data from patients undergoing a simulated 24-hour time period while being monitored with capnography.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Respiratory Rate

Currently open trials in the same condition.

Other Medtronic Cardiac Rhythm and Heart Failure trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04506684.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing